Is MERCK Kommanditgesellschaft auf Aktien (ETR:MRK) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
German (DAX) Pharma Industry Analysis
UpdatedJan 19, 2022
DataAggregated Company Financials
Companies7
- 7D-3.0%
- 3M-0.3%
- 1Y14.7%
- YTD-7.3%
Over the last 7 days, the Pharma industry has dropped 3.0%, driven by a decline by MERCK Kommanditgesellschaft auf Aktien of 5.5%. This takes the industry's 12 month performance to a gain of 15%.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Wed, 19 Jan 2022 | €138.3b | €63.1b | €3.1b | 32.8x |
| Fri, 17 Dec 2021 | €148.6b | €63.1b | €3.1b | 34.1x |
| Sun, 14 Nov 2021 | €148.1b | €63.0b | €3.0b | 38.3x |
| Tue, 12 Oct 2021 | €132.7b | €61.2b | -€4,717,516,252.00 | 35.9x |
| Thu, 09 Sep 2021 | €138.5b | €61.2b | -€4,716,670,252.00 | 32.4x |
| Sat, 07 Aug 2021 | €128.9b | €61.2b | -€4,716,670,252.00 | 30.1x |
| Fri, 30 Apr 2021 | €120.7b | €59.6b | -€12,510,147,423.00 | 27.9x |
| Mon, 01 Feb 2021 | €112.4b | €59.8b | -€13,556,792,870.00 | 30.1x |
| Thu, 05 Nov 2020 | €97.6b | €60.3b | -€14,034,964,373.38 | 28.1x |
| Sun, 09 Aug 2020 | €105.0b | €61.3b | -€5,793,814,704.00 | 30.1x |
| Sat, 02 May 2020 | €107.7b | €61.7b | €4.3b | 28.6x |
| Tue, 04 Feb 2020 | €124.4b | €60.5b | €3.8b | 28.2x |
| Fri, 08 Nov 2019 | €113.4b | €59.5b | -€330,531,806.00 | 33.2x |
| Thu, 01 Aug 2019 | €96.6b | €58.6b | €1.5b | 35.9x |
| Sun, 05 May 2019 | €98.5b | €55.6b | €1.6b | 44x |
| Wed, 06 Feb 2019 | €103.2b | €52.2b | €2.6b | 28.1x |
PE Ratio
28.1x
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 32.2x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 6.2% per year over the last three years, and revenues for these companies have grown 6.5% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the German Pharma industry?
| Pharma | -3.00% | |
Industry PE: Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 32.2x. However analysts are expecting annual earnings growth of 18%, which is lower than the prior year's growth of 43% per year. So the market might believe that analysts are underestimating future growth.
Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 18% over the next 5 years. However this is lower than its past earnings growth rate of 43% per year.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €52.06 | 1.5% +€746.6m | -1.8% | PE230.4x | |
| 93M1 MPH Health Care | €25.40 | 5.0% +€5.1m | 12.4% | PS4.9x |
